Improved Detection of Polyomavirus in Merkel Cell Carcinoma
|
By LabMedica International staff writers Posted on 20 Nov 2012 |
|
An improved detection system suggests that all Merkel cell carcinomas (MCC), a rare skin cancer, harbor Merkel polyomavirus.
The sensitivity of detection of Merkel polyomavirus (MCPyV) in MCC has been improved, enabling high-confidence discrimination between virus-positive and virus-negative tumors.
A team of scientists collaborating with those at the Dana Farber Institute (Boston, MA, USA) analyzed 75 archival formalin-fixed, paraffin-embedded (FFPE) tissue samples of MCC tumor specimens obtained from 60 patients. They performed immunohistochemistry staining with a newly developed mouse monoclonal antibody specific for MCPyV large T antigen. They also developed several quantitative polymerase chain reaction (qPCR) primers and probe sets to determine the viral copy number per tumor cell. Furthermore, they performed mass spectrometry based genotyping of 112 oncogenes and tumor suppressor genes from DNA extracted from these same tumor samples.
The newly developed monoclonal antibody Ab3 showed markedly increased sensitivity in detecting MCPyV large T antigen in 56 of 58 (97%) MCC tumors tested compared with another monoclonal antibody, known as CM2B4, which detected only 80%. Additionally mutations in the gene tumor protein (TP53) were identified in the two tumors that lacked detectable MCPyV. From 75 tumor specimens, only four tumor specimens contained a validated point mutation in any of the 112 oncogenes and tumor suppressor genes evaluated.
The authors concluded that that the presence of MCPyV in MCC is more common than previously reported and that improved detection methods may reveal that all MCC specimens contain viral DNA. The results of this study support the model that the MCPyV T antigens contribute to the pathogenesis of MCC and when their expression is absent, somatic mutations in TP53 and potentially other genes may be selected during oncogenesis. The study was published on November 1, 2012, in the Journal of Clinical Investigation.
Related Links:
Dana Farber Institute
The sensitivity of detection of Merkel polyomavirus (MCPyV) in MCC has been improved, enabling high-confidence discrimination between virus-positive and virus-negative tumors.
A team of scientists collaborating with those at the Dana Farber Institute (Boston, MA, USA) analyzed 75 archival formalin-fixed, paraffin-embedded (FFPE) tissue samples of MCC tumor specimens obtained from 60 patients. They performed immunohistochemistry staining with a newly developed mouse monoclonal antibody specific for MCPyV large T antigen. They also developed several quantitative polymerase chain reaction (qPCR) primers and probe sets to determine the viral copy number per tumor cell. Furthermore, they performed mass spectrometry based genotyping of 112 oncogenes and tumor suppressor genes from DNA extracted from these same tumor samples.
The newly developed monoclonal antibody Ab3 showed markedly increased sensitivity in detecting MCPyV large T antigen in 56 of 58 (97%) MCC tumors tested compared with another monoclonal antibody, known as CM2B4, which detected only 80%. Additionally mutations in the gene tumor protein (TP53) were identified in the two tumors that lacked detectable MCPyV. From 75 tumor specimens, only four tumor specimens contained a validated point mutation in any of the 112 oncogenes and tumor suppressor genes evaluated.
The authors concluded that that the presence of MCPyV in MCC is more common than previously reported and that improved detection methods may reveal that all MCC specimens contain viral DNA. The results of this study support the model that the MCPyV T antigens contribute to the pathogenesis of MCC and when their expression is absent, somatic mutations in TP53 and potentially other genes may be selected during oncogenesis. The study was published on November 1, 2012, in the Journal of Clinical Investigation.
Related Links:
Dana Farber Institute
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
New
TORCH Infections Test
TORCH Panel
Latest Pathology News
- AI Model Predicts Patient Response to Bladder Cancer Treatment
- New Laser-Based Method to Accelerate Cancer Diagnosis
- New AI Model Predicts Gene Variants’ Effects on Specific Diseases
- Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
- Pre-Analytical Conditions Influence Cell-Free MicroRNA Stability in Blood Plasma Samples
- 3D Cell Culture System Could Revolutionize Cancer Diagnostics
- Painless Technique Measures Glucose Concentrations in Solution and Tissue Via Sound Waves
- Skin-Based Test to Improve Diagnosis of Rare, Debilitating Neurodegenerative Disease
- Serum Uromodulin Could Indicate Acute Kidney Injury in COVID-19 Patients
- AI Model Reveals True Biological Age From Five Drops of Blood
- First-Of-Its-Kind AI Tool Visualizes Cell’s ‘Social Network’ To Treat Cancer
- New Test Diagnoses High-Risk Childhood Brain Tumors
- Informatics Solution Elevates Laboratory Efficiency and Patient Care
- Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread
- New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis
- New Technique Predicts Aggressive Tumors Before They Metastasize
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
Molecular Diagnostics
view channel
Novel Point-of-Care Technology Delivers Accurate HIV Results in Minutes
HIV diagnostic methods have traditionally relied on detecting HIV-specific antibodies, which typically appear weeks after infection. This delayed detection has hindered early diagnosis, complicating patient... Read more
Blood Test Rules Out Future Dementia Risk
Previous studies have suggested that specific biomarkers, such as tau217, Neurofilament Light (NfL), and Glial Fibrillary Acidic Protein (GFAP), may be valuable for early dementia diagnosis.... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read more
Technology
view channel
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read moreIndustry
view channel
New Collaboration to Advance Microbial Identification for Infectious Disease Diagnostics
With the rise of global pandemics, antimicrobial resistance, and emerging pathogens, healthcare systems worldwide are increasingly dependent on advanced diagnostic tools to guide clinical decisions.... Read more
